The neuro-immuno-cutaneous-endocrine network: Relationship between mind and skin

Dermatologic Therapy

Volumn 16, Issue 2, 2003, Pages 123-131

  Brazzini, Benedetta ^a   Ghersetich, Ilaria ^a   Hercogova, Jana ^b   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

MSH; Mind; Neuro immuno cutaneous endocrine network; Skin

Indexed keywords

ALPHA INTERMEDIN;

ALTERNATIVE MEDICINE; BRAIN; CARBOXY TERMINAL SEQUENCE; ENDOCRINE SYSTEM; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; PROTEIN FUNCTION; REVIEW; SKIN; SKIN INFLAMMATION;

ALPHA-MSH; ENDOCRINE SYSTEM; HUMANS; NEUROIMMUNOMODULATION; SKIN DISEASES; SKIN PHYSIOLOGY;

EID: 0043173935     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8019.2003.01621.x     Document Type: Review

References (98)

1. O'Sullivan RL, Lipper G, Lerner EA. The neuro-immunocutaneous-endocrine network: relationship of mind and skin. Arch Dermatol 1998: 134: 1431-1435.
2. Wilkin JK. The red face: flushing disorders. Clin Dermatol 1993: 11: 211-223.
3. Langhans W, Hrupka B. Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 1999: 33: 415-424.
4. Sewter CP, Digby JE, Blows F, Prins J, O'Rahily S. Regulation of tumor necrosis factor-α release from human adipose tissue in vitro. J Endocrinol 1995: 163: 33-38.
5. Ghersetich I, Freedman D, Lotti T. Balneology today. J Eur Acad Dermatol Venereol 2000: 14: 346-348.
6. Slominski A, Wortsman J, Paus R, Luger T, Salomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000: 80: 979-1020.
7. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev 2000: 21: 457-487.
8. Lotti T, Bianchi B, Brazzini B, Ghersetich I. Can the brain inhibit inflammation generated in the skin? The lesson of α-melanocyte-stimulating hormone. Int J Dermatol 2001: 41: 311-18.
9. Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview. Eur J Dermatol 1998: 8: 299-306.
10. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansle JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998: 7: 81-96.
11. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997: 137: 843-850.
12. Besedovsky HO, Del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996: 17: 64-102.
13. Pennisi E. Tracing molecules that make the brain-body connection. Science 1997: 275: 930-931.
14. Plotnikoff NP, Faith RE, Murgo AJ, Good RA. Cytokines: stress and immunity. Boca Raton, FL: CRC Press, 1999: 102-109.
15. Scholzen TE, Brzoska T, Kalden D-H, O'Reilly FO, Armstrong CA. Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormone in the skin: mediators of photodermatitis and cutaneous inflammation. J Invest Dermatol Symp Proc 1999: 2: 55-59.
16. Lotti T, Hautmann G, Panconesi E. Neuropeptides and skin. J Am Acad Dermatol 1995: 33: 482-496.
17. Pennisi E. Neuroimmunology: tracing molecules that make the brain-body connection. Science 1997: 275: 930-931.
18. Blalock JE. The syntax of immune neuroendocrine communinication. Immunol Today 1994: 15: 504-511.
19. Manuck SB, Cohen S, Rabin BS. Individual differences in cellular immune response to stress. Psychol Sci 1991: 2: 111-115.
20. Hickie I, Hickie C, Lloyd A. Impaired in vivo responses in patients with melancholia. Br J Psychiatry 1993: 162: 651-657.
21. Gupta MA, Gupta AK, Schork NJ. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994: 56: 36-40.
22. Bilkis MR, Mark KA. Mind-body medicine. Arch Dermatol 1998: 134: 1437-1441.
23. Locke SE, Ransil BJ, Zachariae R. Effect of hypnotic suggestion on the delayed-type hypersensitivity response. JAMA 1994: 272: 47-52.
24. Zachariae R, Bjerring P, Arendt-Nielsen L. Modulation of type I and type IV delayed immunoreactivity using direct suggestion and guided imagery during hypnosis. Allergy 1989: 44: 573-542.
25. Zachariae R, Bjerring P. The effect of hypnotically induced analgesia on flare reaction of the cutaneous histamine prick test. Arch Dermatol Res 1990: 282: 539-543.
26. Zachariae R, Jørgensen MM, Christensen S, Bjerring P. Effects of relaxation on the delayed-type hypersensitivity (DTH) reaction to diphenylcyclopropenone (DCP). Allergy 1997: 52: 760-764.
27. Zachariae R, Bjerring P. Increase and decrease of delayed cutaneous reactions obtained by hypnotic suggestions during sensitisation: studies on dinitrochlorobenzene and diphenylcyclopropenone. Allergy 1993: 48: 6-11.
28. Zachariae R. Effects of hypnotic suggestions on UVB-radiation induced erythema and skin blood flow. Photoderm Photoimmunol Photomed 1994: 10: 154-160.
29. Zachariae R, Bjerring P, Zachariae C, Arendt-Nielsen L, Nielsen T, Eldrup E. Monocyte chemotactic activity in sera after hypnotically induced emotional states. Scan J Immunol 1991: 34: 71-79.
30. Zachariae R, Jinquan T, Peterson KS, Simonsen C, Zachariae C, Hansen JB. Changes in cellular immune function after immune specific guided imagery and relaxation in high and low hypnotizable healthy subjects. Psychother Psychosomat 1994: 61: 74-92.
31. Zachariae R, Øster H, Bjerring P, Kragballe K. Effects of psychological intervention on psoriasis: a preliminary report. J Am Acad Dermatol 1996: 34: 1008-1015.
32. Wintzen M, Gilchrest B. Proopiomelanocortin, its derived peptides and the skin. J Invest Dermatol 1996: 106: 3-10.
33. Jeffcoate WJ, Rees LH, Lowry PJ. β-lipotropin in human plasma and cerebrospinal fluid: radioimmunoassay evidence for β-lipotropin and β-endorphin. J Endocrinol 1978: 77: 278-288.
34. Austen BM, Smyth DG, Snell CR. α-endorphin, β-endorphin and Met-enkephalin are formed extracellularly from lipotropin C fragment. Nature 1977: 269: 619-621.
35. Walter P, Gilmore R, Blobel G. Protein translocation across the endoplasmatic reticulum. Cell 1984: 38: 5-8.
36. Hoellt V. Precursors of opioid peptides and their gene regulation. Clin Neuropharmacol 1992: 15(suppl 1): 50A-51A.
37. Smith AI, Funder JW. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 1988: 9: 159-178.
38. Krieger DT, Liotta AS. Pituitary hormones in brain: where, how and why? Science 1979: 205: 366-370.
39. Pintar JE, Schachter BS, Herman AB. Characterization and localization of proopiomelanocortin messenger RNA in the adult rat testes. Science 1984: 225: 632-634.
40. De Bold CR, Nicholson WE, Orth DN. Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues. Endocrinology 1988: 122: 2648-2657.
41. Slominski A, Wortsman J, Mazurkiewicz J. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993: 122: 658-666.
42. Clark AJL, Lavender PM, Coates P. In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA. Mol Endocrinol 1990: 4: 1737-1743.
43. Young SL, Searles RP, Kaynard AH. Specific inhibition of protein kinase A in granulosa cells abolishes gonadotropin regulation of the proopiomelanocortin promoter. J Biol Chem 1991: 266: 15839-15844.
44. Vale W, Spiess J, Rivier C. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 1981: 213: 1394-1397.
45. Brown SL, Smith LR, Blalock JL. Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells. J Immunol 1987: 139: 3181-3183.
46. Shiomi H, Watson SJ, Kelsey JE. Pretranslational and posttranslational mechanisms for regulating β-endorphinadrenocorticotropin of the anterior pituitary lobe. Endocrinology 1986: 119: 1793-1799.
47. Guillemin R, Vargo T, Rossier J. β-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 1977: 197: 1367-1369.
48. Kavelaars A, Ballieux RE, Heijnen CJ. The role of IL-1 in the corticotropin releasing factor and arginine-vasopressin-induced secretion of immunoreactive β-endorphin by human peripheral blood mononuclear cells. J Immunol 1989: 142: 2338-2342.
49. Thody AJ, Ridley K, Penny RJ, Chalmers R, Fisher C, Shuster S. MSH peptides are present in mammalian skin. Peptides 1983: 4: 813-816.
50. Schauer E, Trautinger F, Kock A, et al. Proopiomelanocortin derived peptides are synthesized and released by human keratinocytes. J Clin Invest 1994: 93: 2258-2262.
51. Teofoli P, Guarcello V, Lotti T, Panconesi E. Detection of mRNA encoding proopiomelanocortin (POMC) in the epidermoid cell line A431. Int J Immunopathol Pharmacol 1997: 10: 69-71.
52. Farooqui JZ, Mediano EE, Boissy KE, Tigelaar RE, Nordlund JJ. Thy-1 + dendritic cells express truncated form of POMC RNA. Exp Dermatol 1995: 4: 297-301.
53. Wintzen M, Gilchrest BA. Proopiomelanocortin, its derived peptides, and the skin. J Invest Dermatol 1996: 106: 3-10.
54. Teofoli P, Motoki K, Lotti T, Uitto J, Mauviel A. Proopiomelanocortin (POMC) gene expression by normal skin and keloid fibroblasts in culture: modulation by cytokines. Exp Dermatol 1997: 6: 111-115.
55. Bohm M, Schulte U, Hartmeyer M, Scholzen T, Becher E, Luger TA. Human dermal fibroblasts express melanocortin-1 receptors and respond to alpha-melanocyte stimulating hormone with secretion of interleukin-6 and interleukin-8. J Invest Dermatol 1997: 108: 593.
56. De Luca M, Siegrist W, Bondanza S, Mathor M, Cancedda R, Eberle AN. Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors. J Cell Sci 1993: 105: 1079-1084.
57. Bhardwaj RS, Becher E, Mahnke K, et al. Evidence of the expression of a functional melanocortin receptor 1 by human keratinocytes. J Invest Dermatol 1996: 106: 817.
58. Hartmeyer M, Scholzen T, Becher E, et al. Human microvascular endothelial cells (HMEC-1) express the melanocortin receptor type 1 and produce increased levels of IL 8 upon stimulation with α MSH. J Immunol 1997: 159: 1930-1937.
59. Armstrong CA, Ansel JC, Luger TA. Melanocytic cell cytokines. In: Luger TA, Schwarz T, eds. Epidermal growth factors and cytokines. New York: Marcel Dekker, 1994: 433-450.
60. Thody AJ, Graham A. Does alpha-MSH have a role in regulating skin pigmentation in humans? Pigment Cell Res 1998: 11: 265-274.
61. Hunt G, Donatien PD, Cresswell JE, Thody AJ. The effect of alpha-MSH on the attachment of human melanocytes to laminin and fibronectin. Evidence for specific alpha-MSH receptors on these cells. Ann N Y Acad Sci 1993: 680: 549-551.
62. Simon MM, Bhardwaj RS, Aragane Y, Schwarz A, Schwarz T, Luger TA. POMC-derived peptide hormones alpha-MSH and ACTH affect proliferation and differentiation of cultured human keratinocytes [abstractl. J Invest Dermatol 1994: 103: 419.
63. Thody AJ, Shuster F. Control and function of sebaceous glands. Physiol Rev 1989: 69: 383-416.
64. Boston BA, Cone KD. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 1996: 137: 2043-2050.
65. Lipton JM, Macaluso A, Hiltz ME, Catania A. Central administration of the peptide α MSH inhibits inflammation in the skin. Peptides 1991: 12: 795-798.
66. Macaluso A, McCoy D, Ceriani G, et al. Antiinflammatory influence of a MSH molecules: central neurogenic and peripheral actions. J Neurosci 1994: 14: 2377-2382.
67. Ceriani G, Macaluso A, Catania A, Lipton JM. Central neurogenic antiinflammatory action of a MSH. modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 1994: 59: 138-143.
68. Robertson B, Dostal K, Daynes RA. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL 1-inducible biologic responses. J Immunol 1988: 140: 4300-4307.
69. Catania A, Lipton JM. Alpha-melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev 1993: 14: 564-576.
70. Luger TA, Scholzen T, Brzoska T, Becher E, Slominski A, Paus R. Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte stimulating hormone. Ann N Y Acad Sci 1998: 840: 381-394.
71. Manna SK, Aggarwal BB. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol 1998: 161: 2873-2880.
72. Lipton JM, Catania A. Antiinflammatory actions of the neuroimmunomodulator α MSH. Immunol Today 1997: 18: 140-145.
73. Taylor AW, Streilein JW, Cousins SW. Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1994: 1: 188-194.
74. Bhardwaj RS, Schwarz A, Becher E, et al. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996: 156: 2517-2521.
75. Cannon JG, Tatro JB, Reichlin S, Dinarello CA. Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 1986: 137: 2232-2236.
76. Grabbe S, Bhardwaj RS, Steinert M, Mahnke K, Schwarz T, Luger TA. Alpha-melanocyte stimulating hormone induces hapten-specific tolerance in mice. J Immunol 1996: 156: 473-478.
77. Grabbe S, Bhardwaj RS, Luger TA. Immunomodulatory capacities of α-melanocyte stimulating hormone and related proopiomelanocortins. In: Ring J, Behrendt H, Vieluf D, eds. New trends in allergy IV. Berlin: Springer-Verlag, 1997: 189-196.
78. Rheins LA, Cotleur AL, Kleier RS, Hoppenjans WB, Sander DN, Nordlund JJ. Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Invest Dermatol 1989: 93: 511-517.
79. Bhardway RS, Becher E, Mahnke K, et al. Evidence for the differential expression of the functional alpha melanocyte stimulating hormone receptor MC-1 on human monocytes. J Immunol 1997: 158: 3378-3384.
80. Kalden DH, Fastrich M, Scholzen T, Brzoska T, Luger TA, Boltzmann L. α-MSH modulates the expression of LPS-induced adhesion molecules [abstract]. In: Cutaneous neuroimmunomodulation: the proopiomelanocortin system. New York Academy of Sciences Conference, Munster, Germany, September 11-13, 1998.
81. Kalden DH, Merfeld S, Brzoska T, et al. α-melanocyte stimulating hormone (α-MSH) reduces vasculitis in the local Shwartzman reaction [abstract]. In: Cutaneous neuroimmunomodulation: the proopiomelanocortin system. New York Academy of Sciences Conference, Munster, Germany, September 11-13, 1998.
82. Chiao H, Foster S, Thomas R, Lipton J, Star RA. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1986: 97: 2038-2044.
83. Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM. The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1994: 1: 28-32.
84. Luger TA, Lotti T Neuropeptides: role in inflammatory skin diseases. J Eur Acad Dermatol Venereol 1998: 10: 207-211.
85. Hanafin NM, Chen TC, Heinrich G, Segre GV, Holick MF. Cultured human fibroblasts and not cultured human keratinocytes express a PTH/PTHrP receptor mRNA. J Invest Dermatol 1995: 105: 133-137.
86. Orloff JJ, Kats Y, Urena P, Schipani E, Vasavada RC, Philbrick WM. Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous cell carcinoma cell lines. Endocrinology 1995: 135: 3016-3023.
87. Atillasoy EJ, Burtis WJ, Milstone LM. Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) in normal human skin. J Invest Dermatol 1991: 96: 277-280.
88. Kageshita T, Matsui T, Hirai S, Fukada Y, Ono T. Hypercalcemia in melanoma patients associated with increased levels of parathyroid hormone-related protein. Melanoma Res 1999: 9: 69-73.
89. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 2001: 15: 1678-1693.
90. Slominski A, Wortsman AJ, Mazurkiewicz JE, Matsuoka L, Dietrich J. Detection of the proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993: 122: 658-666.
91. Slominski A. Identification of β-endorphin, α-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp Dermatol 1998: 7: 213-216.
92. Bigliardi PI, Bigliardi-Qi M, Buchner S, Rufli T. Expression of m-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 1998: 111: 297-301.
93. Nissen JB, Avarch WW, Hansen ES, Stengaard-Pedersen K, Kragballe K. Increased levels of enkephalin following natural sunlight (combined with salt water bathing at the Dead Sea) and ultraviolet A irradiation. Br J Dermatol 1998: 139: 1012-1019.
94. Johansson O, Liu P-Y, Han S-W, Lindberger M, Ljungdahl A, Wahl-Gren C-F. An immunohistochemical study of neuroactive substances in the skin of atopic dermatitis. Eur J Dermatol 1995: 5: 516-523.
95. Fantani F, Johansson O. Neurochemical markers in human cutaneous Merkel cells. An immunohistochemical investigation. Exp Dermatol 1995: 4: 365-371.
96. Grando S. Biological function of keratinocyte cholinergic receptors. J Invest Dermatol Symp Proc 1997: 2: 41-48.
97. Belmonte C, Cervero F. Neurobiology of nociceptors. New York: Oxford University Press, 1996.
98. Chang YT, Mues G, Pittelkow MR, Hyland K. Cultured human keratinocytes as a peripheral source of mRNA for tyrosine hydroxylase and aromatic L-amino acid decarboxylase. J Inherit Metab Dis 1996: 19: 239-242.